Skip to main content

VOYA INVESTMENT MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1068837 ATLANTA, GA

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$11,432,001
-$1,423,470 QoQ
Shares Held
86,777
-4.3% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 74.49785081300344.ToString("F0")% None 25.502149186996554.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $107,185,058 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
86,777 $11,432,001

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,432,001 86,777
2025-12-31 $12,855,471 90,640
2025-09-30 $12,813,605 91,278
2025-06-30 $15,301,500 121,740
2025-03-31 $16,462,257 148,845
2024-12-31 $19,033,696 139,441
2024-09-30 $14,179,894 123,068
2024-06-30 $20,854,389 151,481
2024-03-31 $20,547,735 148,983
2023-12-31 $17,754,132 134,746
2023-09-30 $20,091,261 178,589
2023-06-30 $16,105,024 170,785
2023-03-31 $16,750,694 165,488
2022-12-31 $19,326,704 161,811
2022-09-30 $13,281,559 125,050
2022-06-30 $7,862,931 80,662
2022-03-31 $6,684,656 71,303
2021-12-31 $5,399,948 63,402
2021-09-30 $3,765,618 39,262
2021-06-30 $3,909,539 40,172
2021-03-31 $2,989,659 30,742
2020-12-31 $3,110,236 32,449
2020-09-30 $3,281,171 34,122
2020-06-30 $4,330,146 35,493
2020-03-31 $2,827,415 32,668